Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAlibaba Health Information Technology Limited

Alibaba Health Information Technology Limited

Healthcare Pharmaceutical Retailers
PortfolioPortfolio WatchlistWatchlist
Company price
0.326 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
759
Market Cap
5612.83M
P/E
17.35

Momentum Score

…

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and healthcare services, including medical checkups, testing, medical consultation, appointment-booking, physical examination, consultation, registration, vaccine, dentistry, psychology, optometry, and nursing services, as well as traditional chinese medicines. In addition, it engages in the digital tracking business; asset management; and operation of internet hospitals, as well as provision of network hospital, research, and Internet information services. Further, the company operates Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. It provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Taobao Instant Commerce, AMap, DingTalk, Freshippo, and Quark. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.33
Low
0.39
High
52 Week Price Range
0.35
Low
0.83
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Alibaba Health Information Technology Limited provides digital healthcare services in China, including online pharmacy retail, health-information platforms and pharmaceutical supply-chain solutions, and is affiliated with the Alibaba ecosystem. Long-term growth may be supported by rising digital-health adoption, an aging population and expanding online pharmaceutical distribution, which could support scale and data-driven services.
Key investment risks include regulatory and pricing pressure in China's healthcare sector, strong competition from online and offline players, data privacy and compliance scrutiny, execution risk in scaling services, and limited liquidity and transparency associated with OTC/Pink listing.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.33
Dividend Yield
15.00%
Revenue TTM
34255.12M
Revenue Per Share
2.13
Gross Profit TTM
8210.12M
Debt / Equity
0.00
ROE
11.33%
Net Debt
-5671.08M
ROCE
9.87%
Diluted EPS TTM
0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax 2193.15M 1559.97M 939.40M 550.99M -252.51M
Minority interest -0.18M 0.41M 0.34M -0.86M 0.39M
Net income 1867.15M 1432.43M 883.48M 533.41M -265.56M
Selling general administrative 2825.36M 390.59M 359.98M 379.49M 395.08M
Selling and marketing expenses - 2258.37M 1776.56M 1768.67M 1981.28M
Gross profit 7917.46M 7432.09M 5895.32M 5701.33M 4107.99M
Reconciled depreciation 53.24M 57.60M 53.68M 63.72M 60.58M
Ebit 1769.79M 1562.58M 945.37M 493.11M -792.29M
Ebitda 1821.14M 1620.18M 999.05M 556.83M -731.72M
Depreciation and amortization 51.34M 57.60M 53.68M 63.72M 60.58M
Operating income 1769.79M 1576.06M 717.40M 493.11M -792.29M
Other operating expenses 31264.27M 29022.23M 26309.15M 26794.80M 21596.46M
Interest expense 1.35M 2.61M 5.97M 5.83M 3.81M
Tax provision 337.88M 127.95M 56.26M 16.73M 13.43M
Interest income 463.43M 464.85M 478.03M 331.59M 209.84M
Net interest income 462.03M 462.24M 472.06M -5.83M 206.02M
Income tax expense 325.83M 127.95M 56.26M 16.73M 13.43M
Total revenue 33034.06M 30598.29M 27026.56M 26763.02M 20577.62M
Total operating expenses 6147.66M 5856.03M 5177.92M 5733.12M 5126.84M
Cost of revenue 25116.60M 23166.20M 21131.23M 21061.68M 16469.62M
Total other income expense net 423.36M -16.09M 222.00M 57.89M 539.78M
Net income from continuing ops 1936.34M 1432.01M 883.14M 534.26M -265.94M
Net income applicable to common shares - - - - -265.56M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 23003.65M 21178.42M 19705.34M 20747.56M 19201.97M
Intangible assets 257.23M 275.22M 292.07M 309.01M 326.21M
Other current assets 1816.37M 687.73M 1774.25M - 63.12M
Total liab 5216.26M 4865.26M 5187.73M 5600.22M 5129.74M
Total stockholder equity 17786.24M 16312.18M 14544.21M 15173.71M 14098.42M
Other current liab 1176.87M 1743.00M 1551.83M 1685.96M 1242.88M
Common stock 142.99M 142.79M 142.78M 119.13M 119.10M
Capital stock 143.55M 142.79M 142.78M 119.13M 119.10M
Retained earnings 3148.98M 1324.46M -11.97M -841.69M -1309.01M
Other liab - - - - 222.85M
Good will 802.22M 810.85M 810.85M 810.85M 810.85M
Other assets - - - - 37.68M
Cash 5730.61M 2218.30M 9553.11M 10917.17M 10547.85M
Total current liabilities 5073.55M 4742.17M 5025.46M 5437.44M 4822.13M
Current deferred revenue 849.18M - - - -
Net debt -5671.08M -2182.78M -9470.94M -10839.37M -10412.44M
Short term debt 29.46M 10.58M 34.19M 37.44M 50.66M
Short long term debt total 59.52M 35.52M 82.17M 77.80M 135.41M
Other stockholder equity 17643.25M 51463.79M 14413.40M 15896.26M 13979.32M
Property plant equipment - - - - 165.11M
Total current assets 15362.54M 12276.18M 13512.24M 14913.79M 13565.51M
Net tangible assets - - - - 12961.35M
Short term investments 4713.00M 5881.55M -694.00M - -
Net receivables 1260.99M 2073.39M 785.14M 578.08M 1073.94M
Inventory 1841.58M 1415.22M 1399.74M 2102.31M 1550.15M
Accounts payable 3018.04M 2852.38M 3350.57M 3714.05M 3528.60M
Accumulated other comprehensive income - -36618.87M -36859.38M - -
Non currrent assets other 3470.23M 93.48M 86.44M 4611.52M 4316.89M
Non current assets total 7641.11M 8902.24M 6193.10M 5833.77M 5636.46M
Capital lease obligations 59.76M 35.52M 82.17M 77.80M 135.41M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments 1560.86M -2596.48M -4880.90M -532.44M 2799.35M
Change to liabilities - - - 0.00M 1029.67M
Total cashflows from investing activities 1647.15M -2596.48M -4880.90M - 1872.31M
Net borrowings - - - - -47.01M
Total cash from financing activities -13.72M -72.52M -1982.39M -111.28M -58.63M
Change to operating activities - - - - -44.39M
Net income 1867.15M 1559.97M 939.40M 550.99M -252.51M
Change in cash 3338.22M -1271.87M -5746.68M -104.58M 2089.15M
Begin period cash flow 2392.39M 3490.17M 9236.85M 9341.43M 7252.27M
End period cash flow 5730.61M 2218.30M 3490.17M 9236.85M 9341.43M
Total cash from operating activities 1509.38M 1395.03M 1079.83M 255.69M 424.36M
Issuance of capital stock 10.76M 4.59M 0.88M 12.89M 9.69M
Depreciation 51.34M 57.60M 53.68M 63.72M 60.58M
Other cashflows from investing activities - -9084.21M 229.28M - -112.09M
Change to inventory -544.15M -107.88M 614.10M -711.69M -129.20M
Change to account receivables -206.70M -273.59M -211.49M -64.63M -201.98M
Sale purchase of stock 0.00M -39.93M -104.57M -81.58M -16.52M
Other cashflows from financing activities -24.09M 0.92M -1838.77M -42.59M -51.80M
Change to netincome - - - - -24.76M
Capital expenditures 8.67M 18.90M 22.78M 5.92M 15.12M
Change in working capital -898.44M -567.97M -337.51M -568.13M 671.12M
Stock based compensation 162.12M 224.53M 266.06M 308.89M 408.10M
Other non cash items 489.34M 120.90M 158.21M -99.78M -462.92M
Free cash flow 1500.72M 1376.13M 1057.05M 249.77M 409.25M

Peer Comparison*

Sector: Healthcare Industry: Pharmaceutical Retailers

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ALBHF
Alibaba Health Information Technology Limited		 -
-%		 0.33 17.35 16.69 0.16 2.11 0.89 13.04
JDHIF
JD Health International Inc		 -
-%		 4.79 15.09 15.11 0.18 1.52 0.59 6.26
ALBBY
Alibaba Health Information Technology Limited		 -
-%		 7.65 34.43 19.84 0.29 3.79 1.73 25.72
RADLY
Raia Drogasil SA ADR		 0.09
3.35%		 2.78 22.35 24.69 0.14 4.59 0.90 10.93
RTEZ
Rest EZ Inc.		 -
-%		 70.00 - - 385518.44 5.92 - -

Profile*

Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and healthcare services, including medical checkups, testing, medical consultation, appointment-booking, physical examination, consultation, registration, vaccine, dentistry, psychology, optometry, and nursing services, as well as traditional chinese medicines. In addition, it engages in the digital tracking business; asset management; and operation of internet hospitals, as well as provision of network hospital, research, and Internet information services. Further, the company operates Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. It provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Taobao Instant Commerce, AMap, DingTalk, Freshippo, and Quark. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

Tower One, Causeway Bay, Hong Kong

852 2583 9333

https://www.alihealth.cn

1394

Name Title Year Born
Mr. Shunyan Zhu Chairman & CEO 1971
Mr. Yanwu Tu CFO & Exec. Director 1979
Mr. Difan Shen COO & Exec. Director 1979
Mr. Chun Chung Kwong Financial Controller NA
Ms. Chun Ka Yan Company Sec. NA
Ka Yan Chun Company Sec. NA
Mr. Difan Shen CEO & Executive Director 1978
Mr. Yanwu Tu CFO & Executive Director 1979
Ms. Hiu Leong Tsui Legal Counsel & Joint Company Secretary NA
Ms. Yin Rui Chief Marketing Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…